AKBA vs NVST · rev $102.7M vs P/E 56, rev $1.44B
Akebia Ther (AKBA) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
AKBA currently screens at market cap $260.1M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the AKBA and NVST stock pages for the full models.
Not investment advice.